P54 ORAL ANTIVIRALS RITONAVIR-NIRMATRELVIR AND MOLNUPIRAVIR ARE HIGHLY EFFECTIVE IN PATIENTS WITH MULTIPLE MYELOMA AND COVID-19; A SINGLE-CENTER, PROSPECTIVE STUDY

Hemasphere · 2023 · PMC10171475

Europe PMC

hedged sentence

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

borderline non-significantp=0.052so close (0.05 < p ≤ 0.1)

Regarding PS, a statistically significant difference of mild versus severe cases was observed (p=0.041), while the difference between mild and moderate cases was borderline non-significant (p=0.052).

also in 47 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.